Literature DB >> 24488239

Sexual maturation among youth with ADHD and the impact of stimulant medication.

Brian Greenfield1, Lily Hechtman, Annamarie Stehli, Timothy Wigal.   

Abstract

OBJECTIVE: Evaluate the differences in achieving puberty between ADHD and non-ADHD participants and the effects of medication on that process among ADHD participants. PROCEDURE: A subset of participants with ADHD from the Multimodal Treatment study of ADHD (n = 342) were compared with respect to Tanner staging to participants from a comparison group without ADHD (n = 159) at the 36-month follow-up assessment. Further comparisons were made for Tanner stages and Auxology of the participants in the ADHD group who were always (n = 61), never (n = 56), newly (n = 74) and inconsistently (n = 116) treated with stimulants.
RESULTS: No statistically significant differences in Tanner stages of sexual development were found between the ADHD and non-ADHD groups at the age of assessment (between 10 and 14 years of age) or among the ADHD medication subgroups, although a trend was observed for stimulant-associated delayed pubertal initiation using auxological analysis.
CONCLUSION: Children with or without ADHD did not differ in Tanner stages at the 3-year follow-up assessment, and exposure to stimulant medication does not appear to affect sexual development within this age range.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24488239     DOI: 10.1007/s00787-014-0521-3

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  7 in total

1.  Pubertal delay in male nonhuman primates (Macaca mulatta) treated with methylphenidate.

Authors:  Donald R Mattison; Tony M Plant; Hui-Min Lin; Hung-Chia Chen; James J Chen; Nathan C Twaddle; Daniel Doerge; William Slikker; Ralph E Patton; Charlotte E Hotchkiss; Ralph J Callicott; Steven M Schrader; Terry W Turner; James S Kesner; Benedetto Vitiello; Dayton M Petibone; Suzanne M Morris
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

2.  Validity of self-report of pubertal maturation in early adolescents.

Authors:  N M Schlossberger; R A Turner; C E Irwin
Journal:  J Adolesc Health       Date:  1992-03       Impact factor: 5.012

3.  Depression of growth in hyperactive children on stimulant drugs.

Authors:  D Safer; R Allen; E Barr
Journal:  N Engl J Med       Date:  1972-08-03       Impact factor: 91.245

4.  The reliability, validity, and unique contributions of self-report by adolescents receiving treatment for attention-deficit/hyperactivity disorder.

Authors:  Bradley H Smith; William E Pelham; Elizabeth Gnagy; Brooke Molina; Steven Evans
Journal:  J Consult Clin Psychol       Date:  2000-06

5.  Growth deficits and attention-deficit/hyperactivity disorder revisited: impact of gender, development, and treatment.

Authors:  Joseph Biederman; Stephen V Faraone; Michael C Monuteaux; Elizabeth A Plunkett; Julie Gifford; Thomas Spencer
Journal:  Pediatrics       Date:  2003-05       Impact factor: 7.124

6.  National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment.

Authors: 
Journal:  Pediatrics       Date:  2004-04       Impact factor: 7.124

7.  Slowing of growth in height and weight on stimulants: a characteristic pattern.

Authors:  A Poulton; C T Cowell
Journal:  J Paediatr Child Health       Date:  2003-04       Impact factor: 1.954

  7 in total
  3 in total

1.  Sexuality in Adults With ADHD: Results of an Online Survey.

Authors:  Priscilla Gregório Hertz; Daniel Turner; Steffen Barra; Laura Biedermann; Petra Retz-Junginger; Daniel Schöttle; Wolfgang Retz
Journal:  Front Psychiatry       Date:  2022-05-16       Impact factor: 5.435

2.  Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.

Authors:  Tobias Banaschewski; Mats Johnson; Peter Nagy; Isabel Hernández Otero; César A Soutullo; Brian Yan; Alessandro Zuddas; David R Coghill
Journal:  CNS Drugs       Date:  2018-05       Impact factor: 5.749

Review 3.  Neuron-Glia Interactions in Neurodevelopmental Disorders.

Authors:  Yoo Sung Kim; Juwon Choi; Bo-Eun Yoon
Journal:  Cells       Date:  2020-09-27       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.